Common Variable Immunodeficiency. Diagnosis, Management, and Treatment.

Immunology and Allergy Clinics of North America

Volumn 35, Issue 4, 2015, Pages 637-658

  Abbott, Jordan K ^a   Gelfand, Erwin W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Antibody deficiency; Autoimmunity; Common variable immunodeficiency; CVID; Immune activation; Lymphoproliferation; Primary immune deficiency

Indexed keywords

AZATHIOPRINE; B LYMPHOCYTE RECEPTOR; CD40 LIGAND; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLIXIMAB; PNEUMOCOCCUS VACCINE; RITUXIMAB; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTHRITIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; BRONCHIECTASIS; CALCIUM SIGNALING; CAMPYLOBACTER JEJUNI; CAUSE OF DEATH; CD19 GENE; CD20 GENE; CD21 GENE; CD27 GENE; CD81 GENE; CHRONIC ENTEROPATHY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOPENIA; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENTEROPATHY; FOLLICULAR LYMPHOMA; GASTRITIS; GASTROINTESTINAL DISEASE; GENE; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GIARDIA INTESTINALIS; GRANULOMA; GRANULOMATOSIS; GRANULOMATOUS LYMPHOCYTIC INTERSTITIAL LYMPHOCYTIC DISEASE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; HYPERPLASIA; ICOS GENE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN REPLACEMENT; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INFLAMMATORY BOWEL DISEASE; INTERSTITIAL LUNG DISEASE; INVARIABLE NATURAL KILLER T CELL; LIVER CIRRHOSIS; LIVER GRANULOMA; LOWER RESPIRATORY TRACT INFECTION; LRBA GENE; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MEMORY CELL; MORTALITY; NATURAL KILLER T CELL; NODULAR REGENERATIVE HYPERPLASIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZING PNEUMONIA; PATIENT CARE; PERNICIOUS ANEMIA; PHENOTYPE; PHYSIOTHERAPY; PIK3CD GENE; PLCG2 GENE; PNEUMONIA; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOSING GASTROENTEROPATHY; PULMONARY PHYSIOTHERAPY; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SALMONELLA; SPLENOMEGALY; TNFRSF13B GENE; TNFRSF13C GENE; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; DISEASE MANAGEMENT; METABOLISM;

COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS;

EID: 84943813357     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2015.07.009     Document Type: Review

References (124)

1. Conley M.E., Notarangelo L.D., Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999, 93(3):190-197.
2. Gelfand E.W., Ochs H.D., Shearer W.T. Controversies in IgG replacement therapy in patients with antibody deficiency diseases. J Allergy Clin Immunol 2013, 131(4):1001-1005.
3. Ameratunga R., Woon S.T., Gillis D., et al. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 2013, 174(2):203-211.
4. European Society for Immunodeficiencies Registry Working Party. Available at: . Accessed August 10, 2015. http://esid.org/Working-Parties/Registry/Diagnosis-criteria.
5. Jaffe E.F., Lejtenyi M.C., Noya F.J., et al. Secondary hypogammaglobulinemia. Immunol Allergy Clin N Am 2001, 21(1):141-163.
6. da Silva S.P., Resnick E., Lucas M., et al. Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol 2011, 31(5):784-791.
7. Daly T.M., Pickering J.W., Zhang X., et al. Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements. Clin Vaccin Immunol 2014, 21(7):982-988.
8. Balloch A., Licciardi P.V., Tang M.L.K. Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used. J Clin Immunol 2013, 33(2):335-341.
9. Bryant A., Calver N.C., Toubi E., et al. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 1990, 56(2):239-248.
10. Warnatz K., Denz A., Dräger R., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99(5):1544-1551.
11. Piqueras B., Lavenu-Bombled C., Galicier L., et al. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003, 23(5):385-400.
12. Warnatz K., Wehr C., Dräger R., et al. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 2002, 206(5):502-513.
13. Wehr C., Kivioja T., Schmitt C., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111(1):77-85.
14. Koopmans W., Woon S.T., Zeng I.S.L., et al. Variability of memory B cell markers in a cohort of common variable immune deficiency patients over 6 months. Scand J Immunol 2013, 77(6):470-475.
15. Chapel H., Lucas M., Lee M., et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112(2):277-286.
16. Chapel H., Lucas M., Patel S., et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012, 130(5):1197-1198.e9.
17. Resnick E.S., Moshier E.L., Godbold J.H., et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012, 119(7):1650-1657.
18. Quinti I., Soresina A., Guerra A., et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011, 31(3):315-322.
19. Gathmann B., Mahlaoui N., CEREDIH, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014, 134(1):116-126.
20. Aghamohammadi A., Abolhassani H., Latif A., et al. Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients. Exp Rev Clin Immunol 2014, 10(10):1405-1417.
21. Grimbacher B., Hutloff A., Schlesier M., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4(3):261-268.
22. Warnatz K., Salzer U., Rizzi M., et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106(33):13945-13950.
23. van Zelm M.C., Reisli I., van der Burg M., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354(18):1901-1912.
24. Kuijpers T.W., Bende R.J., Baars P.A., et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010, 120(1):214-222.
25. Thiel J., Kimmig L., Salzer U., et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol 2012, 129(3):801-810.e6.
26. van Zelm M.C., Smet J., Adams B., et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010, 120(4):1265-1274.
27. Castigli E., Wilson S.A., Garibyan L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37(8):829-834.
28. Salzer U., Chapel H.M., Webster A.D.B., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37(8):820-828.
29. Vorechovsky I., Zetterquist H., Paganelli R., et al. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995, 77(2):185-192.
30. Pieper K., Rizzi M., Speletas M., et al. A common single nucleotide polymorphism impairs B-cell activating factor receptor's multimerization, contributing to common variable immunodeficiency. J Allergy Clin Immunol 2014, 133(4):1222-1225.
31. Orange J.S., Glessner J.T., Resnick E., et al. Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 2011, 127(6):1360-1367.e6.
32. Lopez-Herrera G., Tampella G., Pan-Hammarström Q., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012, 90(6):986-1001.
33. van Montfrans J.M., Hoepelman A.I.M., Otto S., et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129(3):787-793.e6.
34. Kuehn H.S., Ouyang W., Lo B., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 2014, 345(6204):1623-1627.
35. Schubert D., Bode C., Kenefeck R., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014, 20(12):1410-1416.
36. Lucas C.L., Kuehn H.S., Zhao F., et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol 2013, 15(1):88-97.
37. Ombrello M.J., Remmers E.F., Sun G., et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012, 366(4):330-338.
38. Ochs H.D. Common variable immunodeficiency (CVID): new genetic insight and unanswered questions. Clin Exp Immunol 2014, 178(Suppl 1):5-6.
39. Seppänen M., Aghamohammadi A., Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?. Exp Rev Clin Immunol 2014, 10(1):1-5.
40. Montella S., Maglione M., Bruzzese D., et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology 2012, 17(1):87-91.
41. Pulvirenti F., Pentassuglio I., Milito C., et al. Idiopathic non cirrhotic portal hypertension and splenoportal axis abnormalities in patients with severe primary antibody deficiencies. J Immunol Res 2014, 2014:672458.
42. Quinti I., Soresina A., Spadaro G., et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007, 27(3):308-316.
43. Oksenhendler E., Gérard L., Fieschi C., et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46(10):1547-1554.
44. Lin L.-J., Wang Y.-C., Liu X.-M. Clinical and immunological features of common variable immunodeficiency in China. Chin Med J 2015, 128(3):310-315.
45. Ramírez-Vargas N., Arablin-Oropeza S.E., Mojica-Martínez D., et al. Clinical and immunological features of common variable immunodeficiency in Mexican patients. Allergol Immunopathol (Madr) 2014, 42(3):235-240.
46. van de Ven A.A.J.M., Compeer E.B., Bloem A.C., et al. Defective calcium signaling and disrupted CD20-B-cell receptor dissociation in patients with common variable immunodeficiency disorders. J Allergy Clin Immunol 2012, 129(3):755-761.e7.
47. Foerster C., Voelxen N., Rakhmanov M., et al. B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency. J Immunol 2010, 184(12):7305-7313.
48. Yu J.E., Knight A.K., Radigan L., et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 2009, 124(2):349-356. 356.e1-3.
49. Groth C., Drager R., Warnatz K., et al. Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2002, 129(1):133-139.
50. Anzilotti C., Kienzler A.-K., Lopez-Granados E., et al. Key stages of bone marrow B-cell maturation are defective in patients with common variable immunodeficiency disorders. J Allergy Clin Immunol 2015.
51. Guazzi V., Aiuti F., Mezzaroma I., et al. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin Exp Immunol 2002, 129(2):346-353.
52. Isgrò A., Marziali M., Mezzaroma I., et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol 2005, 174(8):5074-5081.
53. Oraei M., Aghamohammadi A., Rezaei N., et al. Naive CD4+ T cells and recent thymic emigrants in common variable immunodeficiency. J Investig Allergol Clin Immunol 2012, 22(3):160-167.
54. Serana F., Airo P., Chiarini M., et al. Thymic and bone marrow output in patients with common variable immunodeficiency. J Clin Immunol 2011, 31(4):540-549.
55. Ochtrop M.L.G., Goldacker S., May A.M., et al. T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood 2011, 118(2):309-318.
56. Melo K.M., Carvalho K.I., Bruno F.R., et al. A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS ONE 2009, 4(7):e6269.
57. Horn J., Manguiat A., Berglund L.J., et al. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009, 156(3):446-454.
58. Arandi N., Mirshafiey A., Jeddi-Tehrani M., et al. Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 2013, 281(2):129-133.
59. Farrington M., Grosmaire L.S., Nonoyama S., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994, 91(3):1099-1103.
60. Oliva A., Scala E., Quinti I., et al. IL-10 production and CD40L expression in patients with common variable immunodeficiency. Scand J Immunol 1997, 46(1):86-90.
61. Di Renzo M., Zhou Z., George I., et al. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation. Clin Exp Immunol 2000, 120(3):503-511.
62. Giovannetti A., Pierdominici M., Mazzetta F., et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178(6):3932-3943.
63. Rezaei N., Aghamohammadi A., Nourizadeh M., et al. Cytokine production by activated T cells in common variable immunodeficiency. J Investig Allergol Clin Immunol 2010, 20(3):244-251.
64. Romberg N., Chamberlain N., Saadoun D., et al. CVID-associated TACI mutations affect autoreactive B cell selection and activation. J Clin Invest 2013, 123(10):4283-4293.
65. Viallard J.-F., Camou F., André M., et al. Altered dendritic cell distribution in patients with common variable immunodeficiency. Arthritis Res Ther 2005, 7(5):R1052-R1055.
66. Martinez-Pomar N., Raga S., Ferrer J., et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol 2006, 144(2):233-238.
67. Taraldsrud E., Fevang B., Aukrust P., et al. Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9. Clin Exp Immunol 2014, 175(3):439-448.
68. Paquin-Proulx D., Santos B.A.N., Carvalho K.I., et al. IVIG immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS One 2013, 8(10):e75199.
69. Perreau M., Vigano S., Bellanger F., et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med 2014, 211(10):2033-2045.
70. Barbosa R.R., Silva S.P., Silva S.L., et al. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin Exp Immunol 2012, 169(3):263-272.
71. Siedlar M., Strach M., Bukowska-Strakova K., et al. Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients. Clin Immunol 2011, 139(2):122-132.
72. Kasztalska K., Ciebiada M., Cebula-Obrzut B., et al. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study. Clin Drug Investig 2011, 31(5):299-307.
73. Gao Y., Workman S., Gadola S., et al. Common variable immunodeficiency is associated with a functional deficiency of invariant natural killer T cells. J Allergy Clin Immunol 2014, 133(5):1420-1428. 1428.e1.
74. Paquin-Proulx D., Sandberg J.K. Persistent immune activation in CVID and the role of IVIG in its suppression. Front Immunol 2014, 5:637.
75. Gelfand E.W. Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med 2012, 367(21):2015-2025.
76. Kaveri S.V., Maddur M.S., Hegde P., et al. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol 2011, 164(Suppl 2):2-5.
77. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92(1):34-48.
78. Rizzi M., Neumann C., Fielding A.K., et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol 2011, 128(6):1371-1374.e2.
79. Wehr C., Gennery A.R., Lindemans C., et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol 2015, 135(4):988-997.
80. Malamut G., Verkarre V., Suarez F., et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010, 105(10):2262-2275.
81. Agarwal S., Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 2013, 11(9):1050-1063.
82. van de Ven A.A.J.M., Janssen W.J.M., Schulz L.S., et al. Increased prevalence of gastrointestinal viruses and diminished secretory immunoglobulin A levels in antibody deficiencies. J Clin Immunol 2014, 34(8):962-970.
83. Woodward J.M., Gkrania-Klotsas E., Cordero-Ng A.Y., et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol 2015, 110(2):320-327.
84. Chua I., Standish R., Lear S., et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2007, 150(2):306-311.
85. Fuss I.J., Friend J., Yang Z., et al. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 2013, 33(4):748-758.
86. Daniels J.A., Torbenson M., Vivekanandan P., et al. Hepatitis in common variable immunodeficiency. Hum Pathol 2009, 40(4):484-488.
87. Ward C., Lucas M., Piris J., et al. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008, 153(3):331-337.
88. Murakawa Y., Miyagawa-Hayashino A., Ogura Y., et al. Liver transplantation for severe hepatitis in patients with common variable immunodeficiency. Pediatr Transplant 2012, 16(6):E210-E216.
89. Maarschalk-Ellerbroek L.J., de Jong P.A., van Montfrans J.M., et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol 2014, 34(6):642-654.
90. Hampson F.A., Chandra A., Screaton N.J., et al. Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders. Clin Radiol 2012, 67(6):587-595.
91. Maglione P.J., Ko H.M., Beasley M.B., et al. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2014, 133(2):535-542.
92. Bates C.A., Ellison M.C., Lynch D.A., et al. Granulomatous- lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004, 114(2):415-421.
93. Bouvry D., Mouthon L., Brillet P.-Y., et al. Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis. Eur Respir J 2013, 41(1):115-122.
94. Roifman C.M., Levison H., Gelfand E.W. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987, 1(8541):1075-1077.
95. Chase N.M., Verbsky J.W., Hintermeyer M.K., et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2012, 33(1):30-39.
96. Prasse A., Kayser G., Warnatz K. Common variable immunodeficiency-associated granulomatous and interstitial lung disease. Curr Opin Pulm Med 2013, 19(5):503-509.
97. Boileau J., Mouillot G., Gérard L., et al. Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. J Autoimmun 2011, 36(1):25-32.
98. Wang J., Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005, 25(1):57-62.
99. Gobert D., Bussel J.B., Cunningham-Rundles C., et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011, 155(4):498-508.
100. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev 2002, 16(1):61-64.
101. Boursiquot J.-N., Gérard L., Malphettes M., et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 2013, 33(1):84-95.
102. Ardeniz Ö., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009, 133(2):198-207.
103. Unger S., Seidl M., Schmitt-Graeff A., et al. Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency. J Clin Immunol 2014, 34(6):615-626.
104. Hatab A.Z., Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 2005, 116(5):1161-1162.
105. Mechanic L.J., Dikman S., Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997, 127(8 Pt 1):613-617.
106. Franxman T.J., Howe L.E., Baker J.R. Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. J Clin Immunol 2014, 34(7):820-827.
107. Lin J.H., Liebhaber M., Roberts R.L., et al. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol 2006, 117(4):878-882.
108. Thatayatikom A., Thatayatikom S., White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 2005, 95(3):293-300.
109. Quinti I., Agostini C., Tabolli S., et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood 2012, 120(9):1953-1954.
110. Kinlen L.J., Webster A.D., Bird A.G., et al. Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1985, 1(8423):263-266.
111. Vajdic C.M., Mao L., van Leeuwen M.T., et al. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?. Blood 2010, 116(8):1228-1234.
112. Bloom K.A., Chung D., Cunningham-Rundles C. Osteoarticular infectious complications in patients with primary immunodeficiencies. Curr Opin Rheumatol 2008, 20(4):480-485.
113. Lee A.H., Levinson A.I., Schumacher H.R. Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum 1993, 22(4):252-264.
114. Swierkot J., Lewandowicz-Uszynska A., Chlebicki A., et al. Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol 2006, 25(1):92-94.
115. Xiao X., Miao Q., Chang C., et al. Common variable immunodeficiency and autoimmunity-an inconvenient truth. Autoimmun Rev 2014, 13(8):858-864.
116. Agarwal S., Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep 2009, 9(5):347-352.
117. Lucas M., Lee M., Lortan J., et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010, 125(6):1354-1360.e4.
118. Orange J.S., Grossman W.J., Navickis R.J., et al. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. Clin Immunol 2010, 137(1):21-30.
119. Ballow M. Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data. Ann Allergy Asthma Immunol 2013, 111(6 Suppl):S2-S5.
120. Castigli E., Wilson S., Garibyan L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39(4):430-431.
121. Pan-Hammarström Q., Salzer U., Du L., et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39(4):429-430.
122. Salzer U., Bacchelli C., Buckridge S., et al. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113(9):1967-1976.
123. Martinez-Pomar N., Detkova D., Aróstegui J.I., et al. Role of TNFRSF13B variants in patients with common variable immunodeficiency. Blood 2009, 114(13):2846-2848.
124. Martinez-Gallo M., Radigan L., Almejún M.B., et al. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes. J Allergy Clin Immunol 2013, 131(2):468-476.